The Hepatitis C Drugs industry has witnessed significant evolution driven by breakthroughs in antiviral therapies and expanded patient access programs. Advancements in direct-acting antivirals (DAAs) and sustained demand for effective cure regimens continue to shape the market landscape. The interplay of innovation and regulatory frameworks defines the industry share and market dynami... https://prateikcmi.livepositively.com/key-drivers-shaping-the-hepatitis-c-drugs-market-globally/